Drug stocks sluggish in early trading
April 14, 2011 at 10:38 AM EDT
Human Genome Sciences is a notable mover among large-cap biotechs.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|